Catalyst Wire Dossier Catalyst Wire Dossier

XP21L

· Xanodyne Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XP21L, covering 2010-06-22 to 2011-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery [Phase 3]

See pricing